A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene

被引:7
作者
Baccouche, S
Mabrouk, I
Said, S
Mosbah, A
Jlidi, R
Gargouri, A
机构
[1] Ctr Biotechnol Sfax, Genet Mol Eucaryotes Lab, Sfax, Tunisia
[2] Fac Med Sousse, Biochim Lab, Sousse, Tunisia
[3] CHU Sahloul Sousse, Serv Urol, Sahloul Sousse, Tunisia
[4] CHU Habib Bourguiba, Lab Anat & Cytol Pathol, Sfax, Tunisia
关键词
TP53; polymorphism; codon; 72; polymerase chain reaction; loss of heterozygosity;
D O I
10.1016/S0304-3835(02)00405-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The polymorphism at codon 72 of the TP53 gene has been extensively studied for its involvement in cancerogenesis and loss of heterozygosity (LOH) detection. Usually, the exon 4 of the TP53 gene is amplified by polymerase chain reaction (PCR) on DNA extracted from blood and tumor tissues, then digested by AccII. In the case of heterozygosity, the comparison of AccII profile from blood and tumor DNA PCR products allowed the identification of a potential LOH in the TP53 locus. This method can be hindered by a partial AccII digestion and/or DNA contamination of non-tumor cells. To circumvent these problems, we have developed a new approach by using the Accll restriction site between exon 4 and exon 6. The PCR amplification of exon 4-6, followed by AccII digestion allowed us to detect without ambiguity any LOH case. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 23 条
  • [1] CODON-72 POLYMORPHISM OF THE TP53 GENE
    ARA, S
    LEE, PSY
    HANSEN, MF
    SAYA, H
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (16) : 4961 - 4961
  • [2] 3 DIFFERENT MUTATIONS IN CODON-61 OF THE HUMAN N-RAS GENE DETECTED BY SYNTHETIC OLIGONUCLEOTIDE HYBRIDIZATION
    BOS, JL
    VERLAANDEVRIES, M
    JANSEN, AM
    VEENEMAN, GH
    VANBOOM, JH
    VANDEREB, AJ
    [J]. NUCLEIC ACIDS RESEARCH, 1984, 12 (23) : 9155 - 9163
  • [3] DELACALLEMARTIN O, 1990, NUCLEIC ACIDS RES, V18, P4963, DOI 10.1093/nar/18.16.4963-a
  • [4] Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China
    Guimaraes, DP
    Lu, SH
    Snijders, P
    Wilmotte, R
    Herrero, R
    Lenoir, G
    Montesano, R
    Meijer, CJLM
    Walboomers, J
    Hainaut, P
    [J]. CANCER LETTERS, 2001, 162 (02) : 231 - 235
  • [5] P53 - AT THE CROSSROADS OF MOLECULAR CARCINOGENESIS AND RISK ASSESSMENT
    HARRIS, CC
    [J]. SCIENCE, 1993, 262 (5142) : 1980 - 1981
  • [6] Klug SJ, 2001, CANCER EPIDEM BIOMAR, V10, P1009
  • [7] Madeleine MM, 2000, CANCER EPIDEM BIOMAR, V9, P225
  • [8] HOW P53 SUPPRESSES CELL-GROWTH
    MARX, J
    [J]. SCIENCE, 1993, 262 (5140) : 1644 - 1645
  • [9] MUTATIONS IN THE P53 GENE OCCUR IN DIVERSE HUMAN-TUMOR TYPES
    NIGRO, JM
    BAKER, SJ
    PREISINGER, AC
    JESSUP, JM
    HOSTETTER, R
    CLEARY, K
    BIGNER, SH
    DAVIDSON, N
    BAYLIN, S
    DEVILEE, P
    GLOVER, T
    COLLINS, FS
    WESTON, A
    MODALI, R
    HARRIS, CC
    VOGELSTEIN, B
    [J]. NATURE, 1989, 342 (6250) : 705 - 708
  • [10] p53 codon 72 polymorphism and human papillomavirus associated skin cancer
    O'Connor, DP
    Kay, EW
    Leader, M
    Atkins, GJ
    Murphy, GM
    Mabruk, MJEMF
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (07) : 539 - 542